CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-12-09 | Flynn James E 10% owner | Purchase | +15,775 | $9.00 | $142K | 2,566,310 |
| 2015-12-09 | Flynn James E 10% owner | Purchase | +11,506 | $9.00 | $104K | 976,842 |
| 2015-09-14 | Gulino Richard L. SVP & General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2015-09-14 | Gulino Richard L. SVP & General Counsel | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2015-09-10 | Polymeropoulos Mihael Hristos President and CEO | Exercise or conversion | +147,626 | $4.73 | $698K | 918,943 |
| 2015-09-10 | Polymeropoulos Mihael Hristos President and CEO | Sale | −102,162 | $12.73 | $1.3M | 816,781 |
| 2015-09-10 | Polymeropoulos Mihael Hristos President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −147,626 | 0 | ||
| 2015-09-09 | Polymeropoulos Mihael Hristos President and CEO | Exercise or conversion | +42,747 | $4.73 | $202K | 800,894 |
| 2015-09-09 | Polymeropoulos Mihael Hristos President and CEO | Sale | −29,577 | $12.51 | $370K | 771,317 |
| 2015-09-09 | Polymeropoulos Mihael Hristos President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −42,747 | 147,626 | ||
| 2015-09-08 | Reverberi Gian Piero SVP, General Manager Europe | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2015-09-08 | Reverberi Gian Piero SVP, General Manager Europe | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2015-06-18 | COLA MICHAEL F Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2015-06-18 | Watkins Thomas Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2015-06-18 | PIEN HOWARD H Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2015-06-18 | MILANO VINCENT Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2015-06-18 | DUGAN RICHARD W Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2015-05-22 | Polymeropoulos Mihael Hristos President and CEO | Exercise or conversion | +359,815 | $0.33 | $119K | 927,385 |
| 2015-05-22 | Polymeropoulos Mihael Hristos President and CEO | Sale | −169,238 | $10.36 | $1.8M | 758,147 |
| 2015-05-22 | Polymeropoulos Mihael Hristos President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −359,815 | 0 |
Page 28 of 36 · 717 trades